NASDAQ:ALBO

44.29
0.14 (0.32%) 1d
0
DON'T BUY
Albireo Pharma
A biopharma treating liver and gastrointestinal diseases. It's totally speculative in a very niche market. Even if it hits it out of the park in performance, you won't make much money.
Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Albireo Pharma(ALBO-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Albireo Pharma is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Albireo Pharma(ALBO-Q) Frequently Asked Questions

What is Albireo Pharma stock symbol?

Albireo Pharma is a American stock, trading under the symbol ALBO-Q on the NASDAQ (ALBO). It is usually referred to as NASDAQ:ALBO or ALBO-Q

Is Albireo Pharma a buy or a sell?

In the last year, there was no coverage of Albireo Pharma published on Stockchase.

Is Albireo Pharma a good investment or a top pick?

Albireo Pharma was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Albireo Pharma.

Why is Albireo Pharma stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Albireo Pharma worth watching?

In the last year 0 stock analysts on Stockchase covered Albireo Pharma. The stock is worth watching.

What is Albireo Pharma stock price?

On 2023-03-02, Albireo Pharma (ALBO-Q) stock closed at a price of $44.29.